Mike Taylor

How will practices cope with information for the new GMS contract? Coronary heart disease data recording in five Scottish practices.

F. Sullivan, Libby Morris, L. Campbell, 2003, Informatics in primary care.

A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease

G. Ousler, J. Sheppard, M. Fyfe, 2019, Clinical ophthalmology.

a phase 2 randomized , double-masked , placebo-controlled study of novel nonsystemic kinase inhibitor TOP 1630 for the treatment of dry eye disease

G. Ousler, J. Sheppard, M. Fyfe, 2019 .

Narrow Spectrum Kinase Inhibitors Demonstrate Promise for the Treatment of Dry Eye Disease and Other Ocular Inflammatory Disorders.

S. Hagan, M. Doughty, M. Fyfe, 2018, Investigative ophthalmology & visual science.

Narrow Spectrum Kinase Inhibitors Demonstrate Promise for the Treatment of Dry Eye Disease and Other Ocular Inflammatory Disorders.

S. Hagan, M. Doughty, M. Fyfe, 2018, Investigative ophthalmology & visual science.